Adjuvant Treatment For Braf+ Stage Iii Melanoma: A Case Study To Weigh Ici Versus Targeted Therapies

A New Standard for Stage 3 BRAF+ Melanoma

Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma

Adjuvant Therapy for Resected Stage III Melanoma

Adjuvant Therapy for Stage III Melanoma

Selecting Therapy & Managing Patients With BRAF+ Melanoma

Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma

Adjuvant Options For Stage III Melanoma

COMBI-AD: Dual-Targeted Therapy for Stage 3 Melanoma

Melanoma: BRAF Status and a Neoadjuvant Therapy Approach

Treatment selection for stage III BRAF-mutant melanoma

SYSF Webinar: Treatment Options for Melanoma Patients in the Adjuvant Setting

saveyourskinfdn

Adjuvant Therapy in Melanoma: COMBI-AD Trial

Dr. Weber on Adjuvant Approaches in Stage III Melanoma

Louise Perkins - A Case Study for Immunotherapies and Targeted Therapies

Dr. Blank on Adjuvant Versus Neoadjuvant Approaches in Stage III Melanoma

Advances in Therapy for BRAF-mutant Melanoma

Alternative Adjuvant Approaches in Stage III Melanoma

Molecular Testing for Stage III Melanoma

Dr. Weber on the FDA Approval of Adjuvant Dabrafenib/Trametinib in BRAF-Mutant Melanoma

Adjuvant Therapy for Melanoma: Novel Treatment Options